Nathaniel Martin was born and raised in Western Canada and obtained his PhD degree from the University of Alberta in 2004. He subsequently performed postdoctoral studies at the University of California Berkeley and in 2007 moved to Utrecht University to start his independent career. In 2018 Professor Martin was appointed Chair of Biological Chemistry at Leiden University where his research group works on developing new molecular strategies to address antibiotic resistance (www.martinlab.nl). With a firm foundation in bioorganic and medicinal chemistry, the approaches used by the Martin lab include the design and synthesis of new antibiotics as well as developing small molecule inhibitors of different resistance mechanisms. Prof. Martin has received a number of personal grants and awards in support of his research including the NWO VENI and VIDI grants as well as the ERC consolidator grant. To date, Prof. Martin has published 118 research papers and is named inventor on 9 patents. Since 2023 Prof. Martin is associate editor for the Journal of Medicinal Chemistry, where he oversees submissions on infectious disease and he also sits on the executive board of the Netherlands Centre for One Health (www.ncoh.nl). When not thinking about antibiotics Nathaniel can most likely be found watching his favorite ice-hockey team.